Please login to the form below
Aprecia
This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.
3D printed epilepsy drug launched in the US
3D printed epilepsy drug launched in the US. Aprecia’ s Spritam is now available as a prescription drug. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year, with industry experts hailing it as the catalyst for a new era in
Latest news
-
Printable pharma
Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. “ ... This is the first in a line of central nervous system products Aprecia plans to
-
FDA approves world’s first 3D printed drug
FDA approves world’ s first 3D printed drug. Aprecia’ s epilepsy treatment Spritam seen as the future of drug manufacturing. ... experience. "This is the first in a line of central nervous system products Aprecia plans to introduce as part of our
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Global Healthcare 3D Printing Market Rising at 21.2% CAGR During 2018-2024: Analysis of Key Players, Trends & Drivers
Notable industry competitors are Aprecia Pharmaceuticals, Aspect Biosystems, Bio 3D Technologies, BioBots, Cyfuse Biomedical, Digilab, 3Dynamics Systems, Envision TEC, Luxexcel, Materialise NV, Nano3D Biosciences, Oceanz, Organovo Holdings, regenHU,
-
3D Bioprinting Market Future Trends and Key Industry Analysis of Private Healthcare Market by 2025
Spritam (levetiracetam) that was introduced by a specialty pharmaceutical firm named Aprecia Pharmaceutical gained FDA approval as the first drug with 3D bioprinting and is expected to witness increasing demand across
-
3D Bioprinting Market Future Trends and Key Industry Analysis of Private Healthcare Market by 2025
Spritam (levetiracetam) that was introduced by a specialty pharmaceutical firm named Aprecia Pharmaceutical gained FDA approval as the first drug with 3D bioprinting and is expected to witness increasing demand across
-
3D Bioprinting Market Players Focusing on Leveraging Opportunities in Drug Testing and Cosmetic Surgery Applications
Spritam (levetiracetam) that was introduced by a specialty pharmaceutical firm named Aprecia Pharmaceutical gained FDA approval as the first drug with 3D bioprinting and is expected to witness increasing demand across
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
-
Business Director
-
Competitive Salary Offered
-
Account Manager
-
Negotiable
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Senior Account Manager
-
Competitive Salary Offered
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Medical (Scientific) Director
-
£120, 000 benefits
- Principal Health Economist - North-West
-
Negotiable
-
Associate Director
-
£75, 000-90, 000
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Account Director
-
Competitive Salary Offered
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
-
Systematic Reviewer - Oxford
-
Negotiable
Subscribe to our email news alerts
- Industry frustrated by late warning on 'no deal' Brexit disruption
- UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
- Lucid Group celebrate another magical year at their Winter Meeting
- Biogen picks up another drug from wide-ranging Ionis alliance
- As France protests, Sanofi takes axe to 670 jobs
- Leicester NHS Trust’s staff intranet is integral to HCPs’ working day
PMHub
M&F Health
M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...
Latest intelligence
- Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
- What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
- What everyone forgets about good organisational change in pharma
- Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
- Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
- Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...
Quick links
Infographics
